Roivant Sciences Ltd. (14)

Browse by Contract Category

Contracts

Asset Purchase Agreement, dated as of July 10, 2018, by and among GlaxoSmithKline Intellectual Property Development Ltd., Glaxo Group Limited and Dermavant Sciences GmBH (Filed With SEC on May 14, 2021)
Collaboration and License Agreement, dated as of January 15, 2020, by and between Dermavant Sciences GmbH and Japan Tobacco Inc (Filed With SEC on May 14, 2021)
Roivant Sciences Ltd. Amended and Restated 2015 Equity Incentive Plan (Filed With SEC on May 14, 2021)
Asset Purchase Agreement, dated as of May 29, 2012, by and between Glaxo Group Limited and Welichem Biotech Inc (Filed With SEC on May 14, 2021)
First Amendment to the Asset Purchase Agreement, dated as of August 31, 2012, by and between Glaxo Group Limited and Welichem Biotech, Inc (Filed With SEC on May 14, 2021)
Clinical Supply and Manufacturing Agreement, dated August 20, 2018, by and between Dermavant Sciences GmbH and GlaxoSmithKline (Filed With SEC on May 14, 2021)
Commercial Supply and Manufacturing Agreement, dated April 1, 2019, by and between Dermavant Sciences GmbH and GlaxoSmithKline (Filed With SEC on May 14, 2021)
Funding Agreement, dated as of July 10, 2018, by and between Demavant Sciences GmBH and NovaQuest Co-Investment Fund VIII, L.P (Filed With SEC on May 14, 2021)
First Amendment to Funding Agreement dated as of October 11, 2018, by and between Dermavant Sciences GmBH and NovaQuest Co-Investment Fund VIII, L.P (Filed With SEC on May 14, 2021)
Form of Roivant Sciences Ltd. 2021 Equity Incentive Plan (Filed With SEC on May 14, 2021)
Amended and Restated Employment Agreement between Roivant Sciences, Inc. and Vivek Ramaswamy, dated as of May 14, 2021 (Filed With SEC on May 14, 2021)
Executive Employment Agreement between Roivant Sciences, Inc. and Matthew Gline, dated as of May 14, 2021 (Filed With SEC on May 14, 2021)
Executive Employment Agreement between Roivant Sciences, Inc. and Eric Venker, dated as of May 14, 2021 (Filed With SEC on May 14, 2021)
Executive Employment Agreement between Roivant Sciences, Inc. and Benjamin Zimmer, dated as of May 14, 2021 (Filed With SEC on May 14, 2021)